Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you
Dividend logo
  • STOCK
  • AMGN
  • PRICE AS OF: Jul 16, 05:37 PM EDT
  • $194.88 -$1.03 -0.5%
  • INDUSTRY
  • Biotechnology

AMGN
Stock Dividend Data

DIVIDEND
YIELD
?
?

2.71%
Healthcare Average 0.66%

ANNUALIZED
PAYOUT
?

$5.28
Paid Quarterly

PAYOUT
RATIO
?

38.6%
EPS $13.67

DIVIDEND
GROWTH
?

7 yrs
Since 2011

AMGN
Daily Snapshot

PRICE

$194.88

QUOTE TIME

Jul 16, 05:37 PM

TODAY'S VOLUME

1,824,800

OPEN PRICE

$195.71

DAY'S RANGE

$194.11 - $196.57

PREVIOUS CLOSE

$195.91

52 WEEK LOW / HIGH

$163.31 - $201.23

PERCENT OFF 52 WEEK HIGH

-3.16%

AMGN
Upcoming Dividend Payouts

Sign-up for a Free Trial and we'll notify you as soon as AMGN declares a payout.

By clicking, you agree to our Terms and Privacy Policy

AMGN
Stock Price Recovery History

Ex-Dividend Date Payout Amount Days Taken For Stock Price to Recover
2018-05-16 $1.3200
2018-02-14 $1.3200
2017-11-16 $1.1500
2017-08-15 $1.1500
2017-05-15 $1.1500
2017-02-13 $1.1500
2016-11-14 $1.0000
2016-08-15 $1.0000
2016-05-13 $1.0000
2016-02-11 $1.0000

Capture Amgen Dividend with Much Less Risk

Analyze over 20+ ETFs with Significant Exposure to AMGN

AMGN
Dividend.com DARS Rating™ Breakdown for AMGN

Sign Up
Metric AMGN Rank Healthcare Avg. Ranking Notes
Relative Strength Percent off 52-week high is considerably lower than Benchmark/Peers/Broader Market/Analyst Expectations.
Overall Yield Attractiveness Yield is at or slightly above the Benchmark/Peers/Broader Market/Analyst Expectations.
Dividend Reliability Payout ratio is healthy. Company leaves ample room for reinvesting its earnings to grow.
Dividend Uptrend P/E ratio is at par or slightly below the average of benchmark/peers/broader market/analyst expectation.
Earnings Growth Expected earnings growth is modest and is more representative of a top dividend stock.
DARS Rating

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks

AMGN
Dividend Growth History

Annualized Growth
1994-2012
Annualized Growth
1994-2004
Annualized Growth
2004-2008
Annualized Growth
2008-2012
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Annual
Growth
2017
Consecutive
Years of
Increases
23.5% 15.0% 7 years
Unlock Dividend Growth History

AMGN
Research

AMGN
Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
2017
2016
Unlock Historical Annual Dividend Data & Growth

Brought to You by Mitre Media

AMGN
Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$1.3200 2018-03-07 2018-05-16 2018-05-17 2018-06-08 Yes Regular Quarter
$1.3200 2017-12-12 2018-02-14 2018-02-15 2018-03-08 Yes Regular Quarter
$1.1500 2017-10-24 2017-11-16 2017-11-17 2017-12-08 Yes Regular Quarter
$1.1500 2017-07-28 2017-08-15 2017-08-17 2017-09-08 Yes Regular Quarter
$1.1500 2017-03-07 2017-05-15 2017-05-17 2017-06-08 Yes Regular Quarter
$1.1500 2016-12-20 2017-02-13 2017-02-15 2017-03-08 Yes Regular Quarter
$1.0000 2016-10-14 2016-11-14 2016-11-16 2016-12-08 Yes Regular Quarter
$1.0000 2016-07-22 2016-08-15 2016-08-17 2016-09-08 Yes Regular Quarter
$1.0000 2016-03-02 2016-05-13 2016-05-17 2016-06-08 Yes Regular Quarter
$1.0000 2015-12-15 2016-02-11 2016-02-16 2016-03-08 Yes Regular Quarter
$0.7900 2015-10-14 2015-11-12 2015-11-16 2015-12-07 Yes Regular Quarter
$0.7900 2015-07-28 2015-08-13 2015-08-17 2015-09-08 Yes Regular Quarter
$0.7900 2015-03-04 2015-05-12 2015-05-14 2015-06-05 Yes Regular Quarter
$0.7900 2014-12-17 2015-02-10 2015-02-12 2015-03-06 Yes Regular Quarter
$0.6100 2014-10-17 2014-11-10 2014-11-13 2014-12-05 Yes Regular Quarter
$0.6100 2014-07-25 2014-08-12 2014-08-14 2014-09-05 Yes Regular Quarter
$0.6100 2014-03-05 2014-05-13 2014-05-15 2014-06-06 Yes Regular Quarter
$0.6100 2013-12-13 2014-02-11 2014-02-13 2014-03-07 Yes Regular Quarter
$0.4700 2013-10-16 2013-11-12 2013-11-14 2013-12-06 Yes Regular Quarter
$0.4700 2013-07-26 2013-08-14 2013-08-16 2013-09-06 Yes Regular Quarter
$0.4700 2013-03-06 2013-05-14 2013-05-16 2013-06-07 Yes Regular Quarter
$0.4700 2012-12-13 2013-02-11 2013-02-13 2013-03-07 Yes Regular Quarter
$0.3600 2012-10-11 2012-11-13 2012-11-15 2012-12-07 Yes Regular Quarter
$0.3600 2012-07-19 2012-08-14 2012-08-16 2012-09-07 Yes Regular Quarter
$0.3600 2012-03-15 2012-05-14 2012-05-16 2012-06-07 Yes Regular Quarter
$0.3600 2011-12-15 2012-02-13 2012-02-15 2012-03-07 Yes Regular Quarter
$0.2800 2011-10-13 2011-11-15 2011-11-17 2011-12-08 Yes Regular Quarter
$0.2800 2011-07-28 2011-08-16 2011-08-18 2011-09-08 Yes Regular Quarter
2-for-1 1999-10-20 1999-11-22 1999-11-05 1999-11-19 NM Stock Split NM
2-for-1 1999-01-28 1999-03-01 1999-02-12 1999-02-26 NM Stock Split NM
$0.0002 1997-02-19 1997-03-24 1997-03-21 1997-03-21 Unknown Unknown unknown
2-for-1 1995-07-20 1995-08-16 1995-08-01 1995-08-15 NM Stock Split NM

AMGN
Investor Resources

Learn more about Amgen on:

Company Website For more information, visit the company website.
Investor Relations Here you can find contact information on how to get in touch with the company.
Wiki Page Visit the company page on Wikipedia.
SEC Filings Get access to filings such as 8-K, 10-K, 13-D, Proxy Statements and more.

AMGN
Company Profile

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology

Amgen (AMGN) - this company discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body's response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Knowledge Centers